Amazon OTC Appeal

Amazon OTC Drug Take-down Analysis & POA Appeal Guide

Updated: Jun 2025QTC Global Compliance TeamRegulatory reference content

For Amazon US sellers, evaluating listing blocks due to "Unapproved New Drugs," restricted products, or misbranding, with POA drafting tips.

Key answer

Amazon frequently suspends "Restricted Products" containing sunscreen, antibacterial, or acne claims due to algorithm sweeps or buyer flags. Upon suspension, the seller must submit a Plan of Action (POA) explaining: the root cause (e.g., unapproved claims in copy); corrective actions (e.g., deleting sensitive words); and systemic prevention steps (e.g., pre-listing reviews), backed by NDC screenshots and lab COAs.

Three Core Blocks of an Amazon POA

A successful POA reviewed by Amazon agents must avoid generic templates and focus on concrete root causes and actions.

  • A. Root Cause: admitting exact errors, e.g., "untrained staff added unapproved claims such as cure eczema to the listing page"
  • B. Corrective Action: detailing physical remediation, e.g., "removed all unapproved text from listing, and verified batch COA testing with 3rd-party labs"
  • C. Preventive Action: establishing long-term controls, e.g., "contracted QTC for routine checks before listing publication"

FAQ

Can listings flagged as "Unapproved New Drugs" be recovered?+

Yes. If the product fits under an active FDA monograph (e.g., sunscreen) and has an active NDC code, suspensions are usually triggered by exaggerated claims in bullet points or images. Deleting the keywords and submitting NDC files generally restores the listing.

Next steps

If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.